36.9 F
New York
Friday, January 22, 2021

Moderna [NASDAQ: MRNA] Lost Bid To Arbutus Patent On Vaccine Technology

Must read

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...

Shutterstock [NYSE: SSTK] To Extend Its Agreement With EPA

Shutterstock reported that the company renewed its exclusive contract with the European Pressphoto Agency. The extended contract is to distribute the visual content...

Moderna Inc. [NASDAQ: MRNA] has lost its efforts to discredit U.S. patent owned by Arbutus Biopharma [NASDAQ: ABUS], which has hampered Modernna’s next-generation vaccine efforts, including a coronavirus vaccine.

Moderna Inc. has argued that the Arbutus patent known as ‘069 patent’ should be rejected because it described obvious concepts. But the administrative court run by the US patent and trademark office refused to revoke the patent.

The 069 patent is related to lipid nanoparticle (LNP) that allows the human body to make its own therapeutics protein. Lipid nanoparticle technology is very important for Moderna Inc for the development of vaccines.

Moderna Inc considered Arbutus an obstacle in the vaccine development effort. The court order is disappointing but it doesn’t have an immediate financial impact on the company because of this decision.

Shares of Moderna Inc. traded down 9.49% during the trading of Friday. It had a trading volume of 29.29 million as compared to the average volume of 25.91 million. Moderna Inc has recorded sales of 52.60 million.

If we look at its profitability, its return on investment is 44.90%, return on assets is -29.20%, and return on equity is -37.40%. In the past 52-weeks of trading this company’s stocks has fluctuated between the low of 552.77% and a high of -20.88%.

More articles

Latest article

Tencent Music [NYSE: TME] To Purchase 100% Equity Interest Of Lazy Audio

Tencent Music Entertainment Group reported that the company has signed a contract to purchase 100 percent shares of Lazy Audio. Lazy audio is...

Desktop Metal [NYSE: DM] Inks Agreement To Purchase EnvisionTEC

Desktop Metal reported that the company inked a definitive contract to purchase EnvisionTEC. Desktop Metal will purchase EnvisionTEC for a total consideration of...

Sequential Brands [NASDAQ: SQBG] Partnered With Omega Apparel To Create A New Collection

Sequential Brands Group reported that the company has collaborated with Omega Apparel for its denim business. With this partnership, the company will develop...

Marathon Petroleum [NYSE: MPC] Appoints New CFO

Marathon Petroleum Corp. reported that the company has named Maryann T. Mannen as the CFO and Executive V.P of the company. Maryann has...

QUALCOMM [NASDAQ: QCOM] Announces To Purchase NUVIA For $1.4Billion

QUALCOMM Incorporated reported that its unit, Qualcomm technologies inked a contract to purchase NUVIA.  The company will purchase NUVIA for nearly $1.4B. The...

Trivago [NASDAQ: TRVG] Reported The Purchase Of Weekend.com

Trivago reported that the company has purchased Weekend.com. Weekend it just started based in Germany, its main aim is to provide stimulating getaway...

Arthur J. Gallagher [NYSE: AJG] Reports To Purchase 100% of The Bollington Wilson Group

Arthur J. Gallagher reported that the company has inked a contract to buy 100% of the Bollington Wilson group. Bollington is an insurance...

Grainger [NYSE: GWW] Reports Changes In The Executive Leadership

Grainger reported changes in its Executive leadership. The leading supplier and distributor of MRO products appointed Deidra Merriwether as the Chief Financial officer....